126 related articles for article (PubMed ID: 3999029)
1. Intracellular Ca++ antagonist, HA1004: pharmacological properties different from those of nicardipine.
Asano T; Hidaka H
J Pharmacol Exp Ther; 1985 May; 233(2):454-8. PubMed ID: 3999029
[TBL] [Abstract][Full Text] [Related]
2. Vasodilatory action of HA1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no effect on cardiac function.
Asano T; Hidaka H
J Pharmacol Exp Ther; 1984 Oct; 231(1):141-5. PubMed ID: 6436469
[TBL] [Abstract][Full Text] [Related]
3. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
[TBL] [Abstract][Full Text] [Related]
5. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
6. Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle.
Nakayama K; Kurihara J; Miyajima Y; Ishii K; Kato H
Arzneimittelforschung; 1985; 35(4):687-93. PubMed ID: 4015735
[TBL] [Abstract][Full Text] [Related]
7. Nicardipine actions on smooth muscle cells and neuromuscular transmission in the guinea-pig basilar artery.
Fujiwara S; Kuriyama H
J Pharmacol Exp Ther; 1983 May; 225(2):447-55. PubMed ID: 6302249
[TBL] [Abstract][Full Text] [Related]
8. HA1004, an intracellular calcium antagonist, selectively attenuates pulmonary hypertension in newborn lambs.
Crowley MR; Fineman JR; Soifer SJ
J Cardiovasc Pharmacol; 1994 May; 23(5):806-13. PubMed ID: 7521465
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
Nishikibe M; Nagura J; Kamei K; Fukuroda T
Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068
[TBL] [Abstract][Full Text] [Related]
10. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the endothelium-independent and endothelium-dependent contraction in isolated canine cerebral arteries.
Kanda M; Shirahase H; Wada K; Nakamura S; Matsui H; Fukata F
Arzneimittelforschung; 1996 Jul; 46(7):663-6. PubMed ID: 8842332
[TBL] [Abstract][Full Text] [Related]
11. Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitrophe nyl)- 1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in dogs.
Tsuchida K; Yamazaki R; Kaneko K; Aihara H
Arzneimittelforschung; 1987 Nov; 37(11):1239-43. PubMed ID: 3481545
[TBL] [Abstract][Full Text] [Related]
12. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitropheny l) octyl ester.
Hojo M; Teramoto N; Hata H; Katayama O; Tatsumi H; Shibata S
Arzneimittelforschung; 1992 May; 42(5):621-8. PubMed ID: 1530674
[TBL] [Abstract][Full Text] [Related]
14. Vasodilatory properties in vascular smooth muscle of the calcium antagonist NB-818 compared to nicardipine and nimodipine.
Nishikibe M; Fukuroda T; Nakajima A
Arch Int Pharmacodyn Ther; 1989; 297():98-111. PubMed ID: 2730244
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of CPU-23, a novel L-type calcium channel blocker with a unique molecular structure.
Dong H; Earle ML; Jiang Y; Loutzenhiser KA; Triggle CR
Br J Pharmacol; 1997 Dec; 122(7):1271-8. PubMed ID: 9421272
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of a novel antivasospasm drug, HA1077.
Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Takayasu M; Hidaka H
J Pharmacol Exp Ther; 1987 Jun; 241(3):1033-40. PubMed ID: 3598899
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of two slow channel calcium entry blockers, FR 34235 and nifedipine, on true coronary collateral blood flow.
Gross GJ; Warltier DC; Hardman HF
J Cardiovasc Pharmacol; 1984; 6(1):61-7. PubMed ID: 6199613
[TBL] [Abstract][Full Text] [Related]
18. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
19. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
20. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
Pouleur H; Etienne J; Van Mechelen H; Van Eyll C; Charlier AA; Brasseur LA; Rousseau MF
Postgrad Med J; 1984; 60 Suppl 4():23-8. PubMed ID: 6527976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
